[1] Cui Y, Cao R, Li G, Gong T, Ou Y, Huang J. The effect of lung recruitment maneuvers on post-operative pulmonary complications for patients undergoing general anesthesia: A meta-analysis. PLoS One. 2019;14:e0217405. doi: 10.1371/journal.pone. 0217405.
[2] Nafiu OO, Ramachandran SK, Ackwerh R, Tremper KK, Campbell DA Jr, Stanley JC. Factors associated with and consequences of unplanned post-operative intubation in elderly vascular and general surgery patients. Eur J Anaesthesiol. 2011;28:220-224. doi: 10.1097/EJA.0b013e328342659c.
[3] Ferrando C, Suarez-Sipmann F, Tusman G. Gracia E, Mugarra A, Arocas B et al. Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial. Lancet Respir Med. 2018;6:193-203. doi: 10.1016/S2213-2600(18)30024-9.
[4] PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology, Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014;9:495-503. doi: 10.1016/S0140-6736(14)60416-5.
[5] Investigators TLV. Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS-an observational study in 29 countries. Eur J Anaesthesiol. 2017;34:492-507. doi: 10.1097/EJA.0000000000000646.
[6] Serpa Neto A, da Costa LGV, Hemmes SNT, Canet J, Hedenstierna G, Jaber S, et al. The LAS VEGAS risk score for prediction of postoperative pulmonary complications: an observational study. Eur J Anaesthesiol. 2018;35:691-701. doi: 10.1097/EJA.0000000000000845.
[7] Munro A, McKeen D, Coolen J. Maternal respiratory distress and successful reversal with sugammadex during intrauterine transfusion with fetal paralysis. Int J Obstet Anesth. 2019;39:129-131. doi: 10.1016/j.ijoa.2019.01.002.
[8] Bose S, Xu X, Eikermann M. Does reversal of neuromuscular block with sugammadex reduce readmission rate after surgery? Br J Anaesth. 2019;122:294-298. doi: 10.1016/j.bja.2018.12.015.
[9] Binczak M, Fischler M, Le Guen M. Efficacy of Sugammadex in Preventing Skin Test Reaction in a Patient With Confirmed Rocuronium Anaphylaxis: A Case Report. A A Pract. 2019;13:17-19. doi: 10.1213/XAA.0000000000000973.
[10] Bruintjes MH, van Helden EV, Braat AE, Dahan A , Scheffer GJ , van Laarhoven CJ, et al. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. Br J Anaesth. 2017;118:834-842. doi: 10.1093/bja/aex116.
[11] Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth. 2014;112:498-505. doi: 10.1093/bja/aet377.
[12] Wu TS, Tseng WC, Lai HC, Huang YH, Wu ZF. Sugammadex and laryngospasm. J Clin Anesth. 2019;56:52. doi: 10.1016/j.jclinane.2019.01.043.
[13] Szental JA, Bramley D. Neostigmine-induced weakness after sugammadex. Anaesthesia. 2019;74:253. doi: 10.1111/anae.14553.
[14] Agrò FE, Pascarella G, Piliego C. Pharmaco-economical and clinical concerns of neuromuscular blockade nowadays: the sugammadex paradox. Minerva Anestesiol. 2019;85:447-448. doi: 10.23736/S0375-9393.18.13365-7.
[15] Garutti L , Errando CL, Mazzinari G, Bellón JM, Díaz-Cambronero O, Ferrando C, et al. Spontaneous recovery of neuromuscular blockade is an independent risk factor for postoperative pulmonary complications after abdominal surgery. A secondary analysis. Eur J Anaesthesiol. 2020; 37:203-211. doi: 10.1097/EJA.0000000000001128.
[16] Amao R, Zornow MH, Cowan RM, Cheng DC, Morte JB, Allard MW. Use of sugammadex in patients with a history of pulmonary disease. J Clin Anesth. 2012;24:289-297. doi: 10.1016/j.jclinane.2011.09.006.
[17]Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008;109:816-824. doi: 10.1097/ALN.0b013e31818a3fee.
[18] Chazot T, Dumont G, Le Guen M, Hausser-Hauw C, Liu N, Fischler M. Sugammade administration results in arousal from intravenous anaesthesia: a clinical and electroencephalographic observation. Br J Anaesth. 2011;106:914-916. doi: 10.1093/bja/aer142.
[19]Dahaba AA, Bornemann H, Hopfgartner E, Ohran M, Kocher K, Liebmann M, et al. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral
index monitoring of propofol/remifentanil anaesthesia. Br J Anaesth. 2012;108:602-606. doi: 10.1093/bja/aer495.
[20]Aho AJ, Kamata K, Yli-Hankala A, Lyytikäinen LP, Kulkas A, Jäntti V. Elevated BIS and entropy values after sugammadex or neostigmine: an electroencephalographic or electromyographic phenomenon? Acta Anaesthesiol Scand. 2012;56:465-473. doi: 10.1111/j.1399-6576.2011.02647.x.
[21] Hristovska AM, Duch P, Allingstrup M, Afshari A. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults.A Cochrane systematic review with meta-analysis and trial sequential analysis. Anaesthesia. 2018;73:631-641. doi: 10.1111/anae.14160.
[22] Gaver RS, Brenn BR, Gartley A, Donahue BS. Retrospective analysis of the safety and efficacy of sugammadex versus neostigmine for the reversal of neuromuscular blockade in children. Anesth Analg. 2019;129;1124-1129. doi: 10.1213/ANE.0000000000004207.
[23]McDonagh DL, Benedict PE, Kovac AL, Drover DR, Brister NW, Morte JB, et al. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium- induced neuromuscular blockade in elderly patients. Anesthesiology. 2011;114:318-29. doi: 10.1097/ALN.0b013e3182065c36.
[24] Kaye AD, Kaye RJ, Cornett EM, Urits I, Orhurhu V , Viswanath O, et al. The role of sugammadex, a novel cyclodextrin compound in modern anesthesia practice: conventional neuromuscular physiology and clinical pharmacology. Expert Rev Clin Pharmacol. 2019;12:917-919. doi: 10.1080/17512433.2019.1659134.
[25] Sasaki N, Meyer MJ, Malviya SA, Stanislaus AB, MacDonald T, Doran ME, et al. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study. Anesthesiology. 2014;121:959-968. doi: 10.1097/ALN.0000000000000440.
[26] Brull SJ, Kopman AF. Current status of neuromuscular reversal and monitoring: challenges and opportunities. Anesthesiology. 2017;126:173-90. doi: 10.1097/ALN.0000000000001409.
[27] Boon M, Martini C, Broens S, Rijnsoever EV, Zwan TVD, Aarts L, et al. Improved postoperative oxygenation after antagonism of moderate neuromuscular block with sugammadex versus neostigmine after extubation in ‘blinded’ conditions. Br J Anaesth. 2016;117:410-411. doi: 10.1093/bja/aew246.
[28] Kirmeier E, Eriksson LI, Lewald H, Fagerlund MJ, Hoeft A, Hollmann M, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multi-centre, prospective observational study. Lancet Respir Med. 2019;7:129-140. doi: 10.1016/S2213-2600(18)30294-7.
[29] Plaud B, Gayat E, Nicolas P. Neuromuscular monitoring and reversal: responses to the POPULAR study. Lancet Respir Med. 2019;7:e5. doi: 10.1016/S2213-2600(18)30464-8.
[30] Fuchs-Buder T. Neuromuscular monitoring and reversal: responses to the POPULAR study. Lancet Respir Med. 2019;7:e3. doi: 10.1016/S2213-2600(18)30464-8.
[31] Lee YJ, Oh AY, Koo BW, Han JW, Park JH, Hong JP ,et al. Postoperative residual neuromuscular blockade after reversal based on a qualitative peripheral nerve stimulator response: A randomised controlled trial. Eur J Anaesthesiol. 2020;37:196- 202. doi: 10.1097/EJA.0000000000001157.
[32] Ledowski T, Falke L, Johnston F, Gillies E, Greenaway M, Mel AD, et al. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal. Eur J Anaesthesiol. 2014;31:423-429. doi: 10.1097/EJA.0000000000000010.